For example: Apple Inc, UTIL, Aluminum
Nu Skin Enterprises Inc
NYSE:NUS
Market Close 11/27
52.50 USD +0.43 (+0.83%)
OPEN:
52.05
DAY RANGE:
51.70 - 52.70
PE:
22.02
PB:
4.36
PS:
1.05
WTD % 3.00
MTD % 6.38
QTD % 4.81
YTD % 28.11
* Updated at market close
Nu Skin Enterprises Inc (NYSE:NUS) opened on Nov 27, 2020 at 52.05 USD and went marginally up by 0.83%. The intraday price range was 51.70 - 52.70 USD and eventually ended the session at 52.50 USD. The stock trade volume was 143,500.00 shares. The company's 52-week range is 12.31 - 57.01 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 2.70 B
Outstanding Stock 55.55 M
Dividend 0.37
Dividend Yield 3.00%
EPS 2.24
YTD Change 28.11%
52 Week's Range 12.31 - 57.01
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning 22.02
Price/Book Value 4.36
Price/Sales 1.05
ROA -
ROE -
Debt/Equity 1.15
Company Self Description
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. The company provides skin care systems and targeted treatment products, including ageLOC Me, customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. It was founded in 1984 and is headquartered in Provo, Utah, United States.
Business Information
Nu Skin Enterprises Inc
Sector Consumer Staples
Industry Personal Products
Exchange NYSE
Top Competitors (Market Close Nov 27, 2020)
  NUS IPAR EPC MED
Daily Change (%) 0.83 -1.05 -2.25 6.18
WTD (%) 3.00 4.49 1.88 15.37
MTD (%) 6.38 34.88 36.08 46.89
QTD (%) 4.81 48.27 27.98 25.49
YTD (%) 28.11 -23.83 15.25 88.33
52-Week Change (%) 34.55 -22.51 13.05 134.19
Stock Performance (Market Close Nov 27, 2020)
  NUS IPAR EPC MED
Daily Change (%) 0.83 -1.05 -2.25 6.18
WTD (%) 3.00 4.49 1.88 15.37
MTD (%) 6.38 34.88 36.08 46.89
QTD (%) 4.81 48.27 27.98 25.49
YTD (%) 28.11 -23.83 15.25 88.33
52-Week Change (%) 34.55 -22.51 13.05 134.19
Key Fundamentals (Market Close Nov 27, 2020)
  NUS IPAR EPC MED
Market Cap 2.70 B 1.75 B 1.94 B 2.43 B
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin 4.80% 8.30% -17.40% 11.20%
P/E Ratio 22.02 35.94 -3.90 21.28
Price to Sales Ratio 1.05 2.99 0.68 2.39
Price to Book Ratio 4.36 4.59 1.43 13.71
Enterprise Value to EBITDA 11.45 21.09 10.88 18.85
ROA - 7.20% -9.80% 37.30%
ROE - 12.90% -22.60% 61.10%
Debt/Equity 1.15 0.48 1.27 0.55
Asset Turnover Ratio 1.49 0.87 0.56 3.33
Current Ratio 1.82 3.05 1.33 2.41
Dividend Yield 3.00% 1.60% 0 2.10%
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 2.68 B 2.28 B 2.21 B 2.25 B
Cost Of Revenue 634.14 M 502.08 M 500.46 M 489.51 M
Gross Profit 2.04 B 1.78 B 1.71 B 1.76 B
Selling General & Administrative Expenses 1.73 B 1.50 B 1.48 B 1.51 B
Research & Development 0.00 0.00 0.00 0.00
Operating Income 240.86 M 274.48 M 231.10 M 244.70 M
Net Income 121.89 M 129.44 M 143.09 M 133.05 M
EPS 2.21 2.45 2.58 2.29
Diluted EPS 2.16 2.36 2.55 2.25
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 623.50 M 623.62 M 683.29 M 675.31 M
Cost Of Revenue 154.03 M 146.66 M 161.85 M 157.46 M
Gross Profit 469.47 M 476.96 M 521.43 M 517.86 M
Selling General & Administrative Expenses 395.27 M 408.31 M 432.32 M 437.18 M
Research & Development 0.00 0.00 0.00 0.00
Operating Income 74.20 M 68.65 M 18.43 M 80.68 M
Net Income 46.35 M 43.00 M -17.76 M 53.15 M
EPS 0.83 0.78 -0.33 0.96
Diluted EPS 0.83 0.77 -0.31 0.94
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 799.24 M 777.79 M 714.34 M 706.39 M
Cash & Cash Equivalents 386.91 M 426.40 M 357.25 M 289.35 M
Total Assets 1.69 B 1.59 B 1.47 B 1.51 B
Total Current Liabilities 439.66 M 447.37 M 399.01 M 407.60 M
Total Liabilities 912.58 M 885.28 M 809.98 M 680.22 M
Shareholder's Equity 781.87 M 704.60 M 664.07 M 825.62 M
Outstanding Stock 55.55 M 52.65 M 54.45 M 57.23 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 788.18 M 747.68 M 799.24 M 826.32 M
Cash & Cash Equivalents 360.63 M 310.29 M 386.91 M 390.07 M
Total Assets 1.79 B 1.76 B 1.69 B 1.75 B
Total Current Liabilities 414.55 M 402.04 M 439.66 M 428.26 M
Total Liabilities 956.15 M 943.91 M 912.58 M 914.10 M
Shareholder's Equity 834.95 M 811.20 M 781.87 M 832.13 M
Outstanding Stock 55.49 M 55.36 M 55.55 M 55.53 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations 202.74 M 302.56 M 275.26 M 322.11 M
Capital Expenditures -70.37 M -60.16 M -50.22 M -56.62 M
Net Cash Flow from Investing Activities -108.76 M -91.96 M -57.86 M -60.85 M
Net Cash Flow from Financial Activities -116.71 M -159.57 M -134.71 M -235.92 M
Free Cash Flow 132.37 M 242.40 M 225.04 M 265.49 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations 82.66 M 302.56 M 275.26 M 322.11 M
Capital Expenditures -15.45 M -13.77 M -28.08 M -13.86 M
Net Cash Flow from Investing Activities -16.30 M -18.14 M -33.52 M -16.99 M
Net Cash Flow from Financial Activities -13.71 M -52.97 M -57.90 M -49.83 M
Free Cash Flow 67.21 M -21.95 M 60.81 M 48.05 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio 22.02 20.54 27.75 28.52
Price to Sales Ratio 1.05 0.99 1.26 1.72
Price to Book Ratio 4.36 5.10 3.92 2.63
Enterprise Value to EBIT 16.00 14.00 12.00 10.00
Enterprise Value to EBITDA 11.45 10.82 8.82 7.47
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - 7.00% 8.40%
ROE - - 15.20% 18.40%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 359.58 M 330.42 M 315.33 M 298.80 M
Current Ratio 1.82 1.74 1.79 1.73
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 1.15 1.26 1.22 0.82
Asset Turnover Ratio - - 1.54 1.49
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.